Both in Pharmaceuticals
Innoviva vs uniQure
Over the past year INVA returned +18.8% and QURE returned −68.1%; their daily moves had a correlation of 0.15.
INVA +18.8% QURE −68.1%Growth of $1, one year, split-adjusted
| Metric | INVA | QURE |
|---|---|---|
| Price | $21.05 | $21.65 |
| Market cap | $1.52B | $1.50B |
| Today | +1.89% | −3.48% |
| 1 month | +1.5% | −43.4% |
| 6 months | −9.9% | +20.9% |
| Year to date | +5.3% | −9.5% |
| 1 year | +15.3% | −63.5% |
| Revenue growth (YoY) | +19.3% | +11.0% |
| Gross margin | 81.3% | 94.0% |
| Net margin | −69.8% | −1387.8% |
| P/E (TTM) | 4.3× | — |
| Price / sales | 3.5× | 80.4× |
| Net cash | $319.0M | $760.2M |
| Dividend yield | — | — |
| Volatility (60d) | 22.6% | 104.9% |
| Short % of float | 10.5% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).